Earnings Reports
Filter News
Found 90,833 articles
-
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
3/29/2024
Guardion Health Sciences, Inc. announced its financial results for the year ended December 31, 2023.
-
Jacobio Pharma Announces 2023 Annual Results
3/29/2024
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results.
-
Can-Fite Reports 2023 Financial Results and Clinical Update
3/28/2024
Can-Fite BioPharma Ltd. announced financial results and clinical updates for the twelve months ended December 31, 2023.
-
CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Business and Financial Results
3/28/2024
CASI Pharmaceuticals, Inc. reported business and financial results for the year ended December 31, 2023, and provided an update on key highlights for 2023.
-
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
3/28/2024
Galera Therapeutics, Inc. announced financial results for the fourth quarter and year ended December 31, 2023 and provided recent corporate updates.
-
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
3/28/2024
Vivos Therapeutics, Inc. announced it plans to release its fourth quarter and full year 2023 financial results after market close today, Thursday, March 28, 2024.
-
Integer Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024
3/28/2024
Integer Holdings Corporation announced that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time / 8 a.m. Eastern Time on Thursday, April 25, 2024.
-
IMUNON Reports 2023 Financial Results and Provides Business Update
3/28/2024
IMUNON, Inc. reported financial results for the year ended December 31, 2023.
-
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
3/28/2024
Monopar Therapeutics Inc. announced fourth quarter and full-year 2023 financial results and summarized recent developments.
-
Psychemedics Corporation Reports 2023 Financial Results
3/28/2024
Psychemedics Corporation, the world’s leading provider of hair testing for drugs of abuse, announced financial results for the year ended December 31, 2023.
-
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update97 patients enrolled
3/28/2024
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced its financial results for the fourth quarter and for the year ended December 31, 2023 and provided a corporate update.
-
Tigermed Reports Full Year 2023 Results
3/28/2024
Hangzhou Tigermed Consulting Co., Ltd., a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2023.
-
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
3/28/2024
TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, reported financial results for the fourth quarter and full year 2023.
-
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
3/28/2024
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter and full year ended December 31, 2023.
-
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
3/28/2024
Kodiak Sciences Inc., reported business highlights and financial results for the quarter and year ended December 31, 2023.
-
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
3/28/2024
Yield10 Bioscience, Inc. announced that the Company will report its fourth quarter and full year 2023 financial results and provide a corporate update on Monday, April 1, 2024.
-
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
3/28/2024
Predictive Oncology, a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility, to accelerate oncologic drug discovery and enable drug development, reported financial and operating results for the year ended December 31, 2023, and provided a corporate update.
-
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
3/28/2024
DarioHealth Corp., a leader in the global digital health market, reported financial results for the fourth quarter 2023 and the full year 2023 and provided a corporate and commercial update.
-
Sequana Medical announces 2023 Full Year Results and 2024 Outlook
3/28/2024
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces its financial results for the year ended 31 December 2023, and provides a business update and outlook for 2024 and beyond.
-
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
3/28/2024
Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, reported financial results for the three months and the year ended December 31, 2023.